[1]
Berik Safçi, S. et al. 2025. The significance of SIRI and SII scores in predicting the effect of omalizumab treatment in patients with severe allergic asthma. Allergologia et Immunopathologia. 53, 4 (Jul. 2025), 1–6. DOI:https://doi.org/10.15586/aei.v53i4.1325.